A detailed history of Private Advisor Group, LLC transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Private Advisor Group, LLC holds 14,407 shares of TGTX stock, worth $498,626. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,407
Previous 13,865 3.91%
Holding current value
$498,626
Previous $246,000 36.59%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

BUY
$17.21 - $25.28 $9,327 - $13,701
542 Added 3.91%
14,407 $336,000
Q2 2024

Aug 05, 2024

BUY
$13.32 - $19.19 $3,889 - $5,603
292 Added 2.15%
13,865 $246,000
Q1 2024

Apr 30, 2024

SELL
$13.02 - $21.3 $794 - $1,299
-61 Reduced 0.45%
13,573 $206,000
Q4 2023

Feb 06, 2024

BUY
$6.68 - $18.81 $91,075 - $256,455
13,634 New
13,634 $232,000
Q3 2020

Nov 02, 2020

SELL
$18.49 - $27.24 $49,090 - $72,322
-2,655 Closed
0 $0
Q2 2020

Aug 17, 2020

BUY
$8.9 - $21.84 $23,629 - $57,985
2,655 New
2,655 $52,000

Others Institutions Holding TGTX

About TG THERAPEUTICS, INC.


  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $5.03B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Private Advisor Group, LLC Portfolio

Follow Private Advisor Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Advisor Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Advisor Group, LLC with notifications on news.